This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Assess historical performance and potential in retirement for SP500 and Total Market funds, focusing on consistency and drawdown behavior.
28,444 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Realtor.com launches AGOYU AI-powered moving quotes, letting users generate real-time estimates from video without in...
A broad ETF focused on exponential technologies is delivering solid returns while avoiding heavy bets on any single s...
As of March 18, 2026, XRP hovered around $1.50 after a brief push above $1.60. Analysts say the CLARITY Act could det...
Noble Mobile announced its acquisition of Helium Mobile, uniting two upstart wireless players in a move aimed at slas...
If Klarna reveals its 2025 earnings trajectory, investors will look at growth, profitability, and risk factors more t...
Investors are watching intuitive machines (lunr) earnings to gauge how a private space era company translates NASA co...
Alphabet delivered margin expansion and robust cloud growth in the latest quarter, underscoring its cash-flow potenti...
February can be a pivotal month for tech investing. This guide reveals three top tech stocks february to consider, pl...
Webull (Bull) 2025 earnings offer a window into user growth, revenue mix, and paths to profitability. This guide brea...
Apple unveils rebuilt Siri at WWDC, sending shares on a brisk intraday swing as investors parse the AI strategy. The ...
The Supreme Court decision clears a path for roughly $180 billion in tariff refunds to importers, yet Goldman Sachs c...